SHP-630

N/A

Report date: 2024/11/29 16:57:20

NME

Base Information

Drug NameSHP-630

Drug Alias NameSHP-630BIK-406

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionRhodopsin modulators

TargetsRhodopsin

Therapy Area/IndicationsRetinitis Pigmentosa

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Clinical)

Highest Status in ChinaN/A

Originator CompaniesShire

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesShire

Active IndicationsN/A

Inactive IndicationsRetinitis Pigmentosa

ATC CodeN/A